FDA Import Refusal SCS-1762322-5/11/2 — Fresenius Kabi USA, LLC
The FDA refused shipment SCS-1762322-5/11/2 from Fresenius Kabi USA, LLC (United States) on November 30, 2018. The refused product falls under Drugs and Biologics — CILASTATIN SODIUM/IMIPENEM (INHIBITOR (DECARBOXYLASE)). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- November 30, 2018
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 64UCY04 CILASTATIN SODIUM/IMIPENEM (INHIBITOR (DECARBOXYLASE))
- Charges
- 75